Risk Factors of Noncompliance to Preventive Mass Drug Administration for Eliminating Lymphatic Filariasis: A Case-Control Study in Jawi District, Northwest Ethiopia
Table 2
Distribution of participants by personal and health provider characteristics, Jawi District, Northwest Ethiopia, June 2021 (n = 690).
Variables
Cases n = 345
Control n = 345
Area of residence
Rural
245 (71)
239 (69.3)
Urban
100 (29)
106 (30.7)
Duration of stay in endemic the area
<16 years
206 (59.7)
197 (57.1)
≥16 years
139 (40.3)
148 (42.9)
Perceived LF as a health risk
No
63 (18.3)
39 (11.3)
Yes
282 (81.7)
306 (88.7)
Overall knowledge of LF (symptoms, transmission, and prevention mechanisms)
Knowledgeable
166 (48.1)
214 (62)
Not knowledgeable
179 (51.9)
131 (38)
Having LLITNs
No
86 (24.9)
75 (21.7)
Yes
259 (75.1)
270 (78.3)
Use of LLITNs (n = 529; 258 cases and 271 controls)
No
42 (16.2)
22 (8.1)
Yes
217 (84.8)
248 (91.9)
Getting adequate information on the CDTIA program
No
126 (36.5)
119 (34.5)
Yes
219 (63.5)
226 (65.5)
Using radio as the main source of information on CDTIA
No
338 (98)
334 (96.8)
Yes
7 (2)
11 (3.2)
Using television as the main source of information on CDTIA
No
343 (99.4)
338 (98)
Yes
2 (0.6)
7 (2)
Using CDDs as the main source of information on CDTIA
No
185 (53.6)
175 (50.7)
Yes
160 (46.4)
170 (49.3
Using HEWs as the main source of information on CDTIA
No
243 (70.4)
250 (72.5)
Yes
102 (29.6)
95 (27.5)
Preference to take treatments
CDDs
153 (44.3)
187 (54.2)
HEWs
155 (44.9)
125 (36.2)
HWs
37 (10.7)
33 (9.6)
If CDDs (n = 340)
Female
88 (57.1)
138 (74.2)
Male
66 (42.9)
48 (25.8)
Experience of drugs side effects
No
285 (82.6)
313 (91)
Yes
60 (17.4)
31 (9)
The perceived capacity of CDDs to distribute drugs
No
178 (51.6)
142 (41.2)
Yes
167 (48.4)
203 (58.8)
Participation during CDDs selection
No
283 (82)
205 (59.4)
Yes
62 (18)
140 (40.6)
Fear of drug side effects
No
315 (91.3)
332 (96.2)
Yes
30 (8.7)
13 (3.8)
LLITNs, long-lasting insecticide-treated nets; CDDs, community drug distributors, CDTIA, community-directed treatment with ivermectin and albendazole; HEWs, health extension workers.